{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T20:46:12Z","timestamp":1783629972369,"version":"3.55.0"},"reference-count":34,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.3892\/or.2015.4526","type":"journal-article","created":{"date-parts":[[2015,12,28]],"date-time":"2015-12-28T05:21:13Z","timestamp":1451280073000},"page":"1493-1500","source":"Crossref","is-referenced-by-count":9,"title":["Expression and regulation of COP1 in chronic lymphocytic leukemia cells for promotion of cell proliferation and tumorigenicity"],"prefix":"10.3892","volume":"35","author":[{"given":"CHUNLING","family":"FU","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YANQING","family":"GONG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XUANXUAN","family":"SHI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HENGLIANG","family":"SHI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YAN","family":"WAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"QINGYUN","family":"WU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KAILIN","family":"XU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2015,12,28]]},"reference":[{"key":"key20180107210601_b1-or-35-03-1493","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1038\/onc.2012.411","article-title":"The biology and clinical significance of acquired genomic copy number aberrations and recurrent gene mutations in chronic lymphocytic leukemia","volume":"32","author":"Malek","year":"2013","journal-title":"Oncogene"},{"key":"key20180107210601_b2-or-35-03-1493","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1093\/carcin\/bgs179","article-title":"miR-181a\/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes","volume":"33","author":"Zhu","year":"2012","journal-title":"Carcinogenesis"},{"key":"key20180107210601_b3-or-35-03-1493","doi-asserted-by":"crossref","first-page":"3","DOI":"10.5772\/38328","article-title":"Selected topics in chronic lymphocytic leukemia pathogenesis","volume-title":"Chronic Lymphocytic Leukemia","author":"Bianchi","year":"2012"},{"key":"key20180107210601_b4-or-35-03-1493","doi-asserted-by":"crossref","first-page":"37","DOI":"10.5772\/27127","article-title":"Dysregulation of apoptosis and proliferation in CLL cells","volume-title":"Chronic Lymphocytic Leukemia","author":"W\u00f3jtowicz","year":"2012"},{"key":"key20180107210601_b5-or-35-03-1493","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1080\/1042819021000006411","article-title":"Increased apoptosis in B-chronic lymphocytic leukemia cells as a result of cyclin D3 down regulation","volume":"43","author":"Wang","year":"2002","journal-title":"Leuk Lymphoma"},{"key":"key20180107210601_b6-or-35-03-1493","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1158\/1078-0432.CCR-10-1030","article-title":"Nitric oxide-donating acetylsalicylic acid induces apoptosis in chronic lymphocytic leukemia cells and shows strong antitumor efficacy in vivo","volume":"17","author":"Razavi","year":"2011","journal-title":"Clin Cancer Res"},{"key":"key20180107210601_b7-or-35-03-1493","first-page":"534","article-title":"Alterations in TP53, cyclin D2, c-Myc, p21WAF1\/CIP1 and p27KIP1 expression associated with progression in B-CLL","volume":"48","author":"Halina","year":"2010","journal-title":"Folia Histochem Cytobiol"},{"key":"key20180107210601_b8-or-35-03-1493","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1182\/blood-2002-01-0189","article-title":"Rapamycin-induced G1 arrest in cycling B-CLL cells is associated with reduced expression of cyclin D3, cyclin E, cyclin A, and survivin","volume":"101","author":"Decker","year":"2003","journal-title":"Blood"},{"key":"key20180107210601_b9-or-35-03-1493","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/sj.leu.2402389","article-title":"Cell cycle progression of chronic lymphocytic leukemia cells is controlled by cyclin D2, cyclin D3, cyclin-dependent kinase (cdk) 4 and the cdk inhibitor p27","volume":"16","author":"Decker","year":"2002","journal-title":"Leukemia"},{"key":"key20180107210601_b10-or-35-03-1493","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.beha.2010.02.001","article-title":"Chronic lymphocytic leukaemia: A disease of activated monoclonal B cells","volume":"23","author":"Damle","year":"2010","journal-title":"Best Pract Res Clin Haematol"},{"key":"key20180107210601_b11-or-35-03-1493","doi-asserted-by":"crossref","first-page":"6051","DOI":"10.4049\/jimmunol.181.9.6051","article-title":"IL-24 induces apoptosis of chronic lymphocytic leukemia B cells engaged into the cell cycle through dephosphorylation of STAT3 and stabilization of p53 expression","volume":"181","author":"Sainz-Perez","year":"2008","journal-title":"J Immunol"},{"key":"key20180107210601_b12-or-35-03-1493","doi-asserted-by":"crossref","first-page":"4497","DOI":"10.1200\/JCO.2007.15.4393","article-title":"Novel insights in chronic lymphocytic leukemia: Are we getting closer to understanding the pathogenesis of the disease?","volume":"26","author":"Caligaris-Cappio","year":"2008","journal-title":"J Clin Oncol"},{"key":"key20180107210601_b13-or-35-03-1493","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.humpath.2005.09.029","article-title":"The proliferation center microenvironment and prognostic markers in chronic lymphocytic leukemia\/small lymphocytic lymphoma","volume":"37","author":"Soma","year":"2006","journal-title":"Hum Pathol"},{"key":"key20180107210601_b14-or-35-03-1493","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1006\/scdb.2000.0203","article-title":"The COP\/DET\/FUS proteins-regulators of eukaryotic growth and development","volume":"11","author":"Schwechheimer","year":"2000","journal-title":"Semin Cell Dev Biol"},{"key":"key20180107210601_b15-or-35-03-1493","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1471-2121-3-30","article-title":"An initial biochemical and cell biological characterization of the mammalian homologue of a central plant developmental switch, COP1","volume":"3","author":"Yi","year":"2002","journal-title":"BMC Cell Biol"},{"key":"key20180107210601_b16-or-35-03-1493","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.tcb.2005.09.007","article-title":"COP1 - from plant photomorphogenesis to mammalian tumorigenesis","volume":"15","author":"Yi","year":"2005","journal-title":"Trends Cell Biol"},{"key":"key20180107210601_b17-or-35-03-1493","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nrc3271","article-title":"Spotlight on the role of COP1 in tumorigenesis","volume":"12","author":"Marine","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"key20180107210601_b18-or-35-03-1493","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1172\/JCI57080","article-title":"Good COP1 or bad COP1? In vivo veritas","volume":"121","author":"Wei","year":"2011","journal-title":"J Clin Invest"},{"key":"key20180107210601_b19-or-35-03-1493","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1126\/science.1093549","article-title":"Human De-etiolated-1 regulates c-Jun by assembling a CUL4A ubiquitin ligase","volume":"303","author":"Wertz","year":"2004","journal-title":"Science"},{"key":"key20180107210601_b20-or-35-03-1493","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/nature02514","article-title":"The ubiquitin ligase COP1 is a critical negative regulator of p53","volume":"429","author":"Dornan","year":"2004","journal-title":"Nature"},{"key":"key20180107210601_b21-or-35-03-1493","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/nature10005","article-title":"COP1 is a tumour suppressor that causes degradation of ETS transcription factors","volume":"474","author":"Vitari","year":"2011","journal-title":"Nature"},{"key":"key20180107210601_b22-or-35-03-1493","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1126\/science.1123374","article-title":"TRB3 links the E3 ubiquitin ligase COP1 to lipid metabolism","volume":"312","author":"Qi","year":"2006","journal-title":"Science"},{"key":"key20180107210601_b23-or-35-03-1493","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/nature06128","article-title":"Insulin modulates gluconeogenesis by inhibition of the coactivator TORC2","volume":"449","author":"Dentin","year":"2007","journal-title":"Nature"},{"key":"key20180107210601_b24-or-35-03-1493","doi-asserted-by":"crossref","first-page":"35464","DOI":"10.1074\/jbc.M801011200","article-title":"COP1 functions as a FoxO1 ubiquitin E3 ligase to regulate FoxO1-mediated gene expression","volume":"283","author":"Kato","year":"2008","journal-title":"J Biol Chem"},{"key":"key20180107210601_b25-or-35-03-1493","doi-asserted-by":"crossref","first-page":"7226","DOI":"10.1158\/0008-5472.CAN-04-2601","article-title":"COP1, the negative regulator of p53, is overexpressed in breast and ovarian adeno-carcinomas","volume":"64","author":"Dornan","year":"2004","journal-title":"Cancer Res"},{"key":"key20180107210601_b26-or-35-03-1493","doi-asserted-by":"crossref","first-page":"8264","DOI":"10.1158\/0008-5472.CAN-10-0749","article-title":"Definition of ubiquitination modulator COP1 as a novel therapeutic target in human hepatocellular carcinoma","volume":"70","author":"Lee","year":"2010","journal-title":"Cancer Res"},{"key":"key20180107210601_b27-or-35-03-1493","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.7150\/ijbs.4778","article-title":"High level of COP1 expression is associated with poor prognosis in primary gastric cancer","volume":"8","author":"Li","year":"2012","journal-title":"Int J Biol Sci"},{"key":"key20180107210601_b28-or-35-03-1493","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1182\/blood-2012-12-476101","article-title":"COP1 targets C\/EBP\u03b1 for degradation and induces acute myeloid leukemia via Trib1","volume":"122","author":"Yoshida","year":"2013","journal-title":"Blood"},{"key":"key20180107210601_b29-or-35-03-1493","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1172\/JCI45784","article-title":"Cop1 constitutively regulates c-Jun protein stability and functions as a tumor suppressor in mice","volume":"121","author":"Migliorini","year":"2011","journal-title":"J Clin Invest"},{"key":"key20180107210601_b30-or-35-03-1493","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4161\/onci.1.1.18400","article-title":"Lymphoblastoid cell line with B1 cell characteristics established from a chronic lymphocytic leukemia clone by in vitro EBV infection","volume":"1","author":"Ros\u00e9n","year":"2012","journal-title":"Oncoimmunology"},{"key":"key20180107210601_b31-or-35-03-1493","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.semcancer.2010.09.003","article-title":"Molecular basis of CLL","volume":"20","author":"Pekarsky","year":"2010","journal-title":"Semin Cancer Biol"},{"key":"key20180107210601_b32-or-35-03-1493","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1600-0609.2008.01196.x","article-title":"High intracellular content of cyclin-dependent kinase inhibitor p27Kip1 in early- and intermediate stage B-cell chronic lymphocytic leukemia lymphocytes predicts rapid progression of the disease","volume":"82","author":"Wolowiec","year":"2009","journal-title":"Eur J Haematol"},{"key":"key20180107210601_b33-or-35-03-1493","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.3324\/haematol.2010.022277","article-title":"Expanded and highly active proliferation centers identify a histological subtype of chronic lymphocytic leukemia (accelerated chronic lymphocytic leukemia) with aggressive clinical behavior","volume":"95","author":"Gin\u00e9","year":"2010","journal-title":"Haematologica"},{"key":"key20180107210601_b34-or-35-03-1493","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1242\/jcs.001222","article-title":"Dynamic FoxO transcription factors","volume":"120","author":"Huang","year":"2007","journal-title":"J Cell Sci"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2015.4526\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T16:06:11Z","timestamp":1515341171000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2015.4526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,28]]},"references-count":34,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2015,12,28]]},"published-print":{"date-parts":[[2016,3]]}},"alternative-id":["10.3892\/or.2015.4526"],"URL":"https:\/\/doi.org\/10.3892\/or.2015.4526","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,28]]}}}